Pharmacoepidemiology News and Research

RSS

The science of pharmacoepidemiology can answer a range of questions regarding how, why, when, where, and by whom a medicine is being used. It is a way of finding out the impact of a medicine as well as the usage results in a large, well-defined population. Also, it can help provide some indication as to how a particular drug is benefitting society and how it may be having a negative impact. Pharmacoepidemiology can be carried out both before and after a medicine is taken to market.

Antipsychotic use during pregnancy not linked to childhood neurodevelopmental disorders or learning difficulties

The use of antipsychotics during pregnancy isn't linked to childhood neurodevelopmental disorders or learning difficulties, UNSW Sydney-led study shows – giving assurance to those concerned about continuing their medications during pregnancy.

18 Mar 2024

Antimicrobial resistance prevalence tied to patient age and sex

A person's age and sex are correlated with the chance that they have a bloodstream infection caused by a bacterium that is resistant to antibiotics, according to a new study published in PLOS Medicine.

15 Mar 2024

Study offers insight into state Medicaid coverage for anti-obesity drugs

Mounting evidence suggests that FDA-approved weight loss medications, such as Wegovy, not only help patients lose weight but also protect against complications from obesity such as cardiovascular disease.

14 Mar 2024

LSHTM researchers receive £2m funding to develop novel vaccines, diagnostics and therapeutics

Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have been awarded £2m funding through the UK Research and Innovation's (UKRI) Technology Missions Fund, to develop novel vaccines, diagnostics and therapeutics.

9 Feb 2024

Researchers receive £2.4 million to generate evidence on the new NHS Pharmacy First service

Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have been awarded £2.4m by the National Institute for Health and Care Research (NIHR) to generate evidence on the new National Health Service (NHS) Pharmacy First service.

6 Feb 2024

SGLT2 inhibitors linked to lower risk of kidney stones in patients with type 2 diabetes

Rates of kidney stones are on the rise in the United States and around the world. Type 2 diabetes is associated with increased risk of kidney stones, but some forms of treatment for this condition may also have the benefit of lowering risk of kidney stones.

31 Jan 2024

AI Integration in the Fight Against Age-Related Macular Degeneration

In this interview, Wen Hwa Lee, CEO, and Chief Scientist at Action Against Age-Related Macular Degeneration (AAAMD), offers an enlightening perspective on merging AI with ophthalmology to forge new paths in healthcare and drug discovery.

From ELRIG (UK) Ltd. 3 Jan 2024

Indoor air pollution from cooking fuels linked to developmental delays in children

Just about everyone knows that cigarette smoke is bad for babies. Should cooking fuels like natural gas, propane and wood be viewed similarly when used indoors?

26 Sep 2023

Amoxicillin vs. amoxicillin-clavulanate: Which is more effective for acute sinusitis in children?

Brigham researchers found that patients prescribed amoxicillin-clavulanate had higher rates of gastrointestinal symptoms and yeast infections than those prescribed amoxicillin.

19 Sep 2023

Men and women with elevated blood sugar levels have greater risk of cardiovascular diseases

Men and women with raised blood sugar levels have 30-50% greater risk of developing cardiovascular diseases even when these levels are below the threshold for diabetes, a new study has shown.

10 Aug 2023

Many top-selling brand-name drugs in Medicare may provide little added therapeutic benefit

Brand-name drugs cost two to three times more in the U.S. than in other countries, but many of the top-selling brand name drugs may provide little added therapeutic benefit.

18 Apr 2023

Serious pneumococcal infection increases the risk of a heart attack significantly

After the onset of serious pneumococcal infections, patients are at a significantly increased risk of having a heart attack, according to a Vanderbilt study published in the journal Clinical Infectious Diseases.

2 Mar 2023

£1.7m NIHR funding to explore how routinely-collected healthcare data can be used to improve clinical guidance

Professor Laurie Tomlinson has been awarded a National Institute for Healthcare Research (NIHR) Research Professorship worth £1.7m to explore how routinely-collected healthcare data can be used to improve clinical guidance.

23 Feb 2023

Study examines postpartum women's experiences during the third wave of COVID-19

In a recent study published in the journal Pharmacoepidemiology, researchers investigated postpartum women’s birth-associated experiences during the third wave of the coronavirus disease 2019 (COVID-19) pandemic in Europe.

7 Feb 2023

Young people treated for sleep disorders with benzodiazepines may be at higher risk of overdose

Teens and young adults who are treated for sleep disorders with benzodiazepines such as Xanax – a medication commonly prescribed to treat anxiety and insomnia – may be at a higher risk of overdose, according to Rutgers researchers.

23 Nov 2022

Newer class of antidiabetic drugs reduced risk of hospitalization for heart failure

In cardiovascular outcome trials among adults with type 2 diabetes (T2D), sodium-glucose co-transporter 2 inhibitors (SGLT-2i) have shown therapeutic promise, including reduced risk of hospitalization for heart failure compared to placebo.

1 Jun 2022

Parallel approach to vaccine trials can lead to faster and more accurate assessment

Some of Rutgers' top health researchers are calling for a change in our approach to developing COVID-19 vaccines, and vaccines to fight future pandemics, to incorporate both conventional and challenge trails.

12 Apr 2022

Risk for anaphylaxis higher with two intravenous iron formulations

Two products commonly administered intravenously to replenish iron levels in the body have a much higher chance of provoking a severe allergic attack, according to Rutgers researchers who conducted a study analyzing the medical records in a large database of older, Medicare patients.

29 Mar 2022

Youth with intentional BZD overdoses more likely to have recent doctor-written prescription

A high number of teens and young adults with an overdose involving a benzodiazepine (BZD), like Xanax, or psychostimulant, like Adderall – medications commonly used to treat mental health issues like attention deficit hyperactivity disorder and anxiety disorders – have a recent medical prescription for a BZD or stimulant, according to Rutgers researchers who say physicians need to weigh the risks and benefits of these medications more closely.

10 Mar 2022

New findings support the routine use of remdesivir in hospitalized COVID-19 patients

Remdesivir, an antiviral drug used to treat COVID-19, increased the likelihood of clinical improvement in COVID-19 patients on low-flow oxygen or no oxygen, according to a new study authored by the Johns Hopkins University School of Medicine, the Johns Hopkins Bloomberg School of Public Health, HCA Healthcare, and Genospace.

18 Jan 2022